Literature DB >> 29940169

Clinical Outcomes of Preloaded Descemet Membrane Endothelial Keratoplasty Grafts With Endothelium Tri-Folded Inwards.

Massimo Busin1, Pia Leon2, Sergio D'Angelo3, Alessandro Ruzza4, Stefano Ferrari4, Diego Ponzin4, Mohit Parekh5.   

Abstract

PURPOSE: To evaluate the initial outcomes and complications of Descemet membrane endothelial keratoplasty (DMEK) using donor tissues tri-folded with the endothelium inwards, preloaded at the Eye Bank, and delivered with bimanual pull-through technique.
DESIGN: Prospective, noncomparative, interventional case series.
METHODS: Setting: Eye bank and tertiary care eye department. PATIENT POPULATION: Forty-six consecutive eyes of 41 patients with Fuchs endothelial dystrophy with or without cataract operated between November 2016 and March 2017. INTERVENTION: DMEK tissues prepared with SCUBA technique and punched to a diameter of 8.25 mm were preloaded with the endothelium tri-folded inwards in an intraocular lens (IOL) cartridge with a 2.2-mm opening filled with the same tissue culture medium contained in the vial used for shipment to the surgeon. Standardized DMEK was performed as a single procedure (n = 15) or in combination with phacoemulsification and IOL implantation (n = 31) within 48 hours from preparation using a bimanual pull-through technique. MAIN OUTCOME MEASURES: Preparation and surgical times, intraoperative and postoperative complications, best spectacle-corrected visual acuity (BSCVA), endothelial cell density (ECD), and graft detachment rate.
RESULTS: Preparation time averaged 26.2 ± 4.1 minutes (range 17-36 minutes), while the surgical time from opening of the stoppers to air fill of the anterior chamber never exceeded 9 minutes (range 3-9 minutes). Surgery was uneventful in all cases. Postoperative complications included graft detachment in 9 of 46 cases (19.6%), successfully managed in all cases by single rebubbling within 6 days from surgery, and glaucoma irresponsive to conservative treatment in 1 of 46 cases (2.1%). In all eyes without comorbidities (35 of 40 eyes) BSCVA was 20/25 (0.097 logMAR) or better as early as 3 months after surgery. Six months postoperatively, ECD was available in 24 of 25 eyes with an endothelial cell loss calculated as a percentage of the preoperative value determined at the eye bank (ranging from 2500 to 2800 cells/mm2) of 29.5% ± 14.8% (range 8.3%-52.1%).
CONCLUSIONS: Delivering a preloaded DMEK tissue, tri-folded with the endothelium inwards, minimizes surgical time and costs without negatively affecting the outcomes of the procedure.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29940169     DOI: 10.1016/j.ajo.2018.06.013

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Comparison of Tri-folded and Scroll-based Graft Viability in Preloaded Descemet Membrane Endothelial Keratoplasty.

Authors:  Kali Barnes; Eric Chiang; Conan Chen; John Lohmeier; Jason Christy; Akash Chaurasia; Allison Rosen; Parth Vora; Stephanie Cai; Anshul Subramanya; Nicholas Durr; Robert Allen; Allen Omid Eghrari
Journal:  Cornea       Date:  2019-03       Impact factor: 2.651

2.  "Endothelium-Out" and "Endothelium-In" Descemet Membrane Endothelial Keratoplasty (DMEK) Graft Insertion Techniques: A Systematic Review With Meta-Analysis.

Authors:  Hon Shing Ong; Hla M Htoon; Marcus Ang; Jodhbir S Mehta
Journal:  Front Med (Lausanne)       Date:  2022-06-14

3.  Clinical outcomes of pre-loaded ultra-thin DSAEK and pre-loaded DMEK.

Authors:  Vito Romano; Luca Pagano; Kunal A Gadhvi; Giulia Coco; Mitchell Titley; Matthew Thomas Fenech; Stefano Ferrari; Hannah J Levis; Mohit Parekh; Stephen Kaye
Journal:  BMJ Open Ophthalmol       Date:  2020-10-16

4.  Aspiration of Tri-folded, Endothelium-In Grafts for Descemet Membrane Endothelial Keratoplasty.

Authors:  Sezen Karakus; Mehrnaz Ighani; Puntakarn Noparat; Marjan Tofigh; Eric Chiang; Kali Barnes; Conan Y Chen; Tiffany S Liu; Allen O Eghrari
Journal:  Cornea       Date:  2019-05       Impact factor: 2.651

5.  Viability of preloaded Descemet membrane endothelial keratoplasty grafts with 96-hour shipment.

Authors:  Conan Chen; Steven Jared Solar; John Lohmeier; Staci Terrin; Satya Baliga; Batya Gold Wiener; Daniel Schouten Lewis; Eric Chiang; Kali Alexandra Barnes; Akash Chaurasia; Allen O Eghrari
Journal:  BMJ Open Ophthalmol       Date:  2021-05-20

6.  Confounding factors influencing the scroll width of Descemet membrane endothelial keratoplasty graft.

Authors:  Mohit Parekh; Stefano Ferrari; Luca Pagano; Martina Angi; Kunal A Gadhvi; Vito Romano
Journal:  Indian J Ophthalmol       Date:  2021-02       Impact factor: 1.848

7.  Early Complications With Preloaded Descemet Membrane Endothelial Keratoplasty Are Not Dependent on Optisol-GS Washout or Trypan Blue Restaining.

Authors:  Miles F Greenwald; Afshan A Nanji; John L Clements; Richard D Stutzman; Christopher G Stoeger; Winston D Chamberlain
Journal:  Cornea       Date:  2021-11-01       Impact factor: 3.152

8.  Clinical Outcomes Of Descemet Membrane Endothelial Keratoplasty Using The Bonfadini-Todd Injector For Graft Insertion.

Authors:  Mehrnaz Ighani; Sezen Karakus; Allen O Eghrari
Journal:  Clin Ophthalmol       Date:  2019-09-20

Review 9.  Evolution of therapies for the corneal endothelium: past, present and future approaches.

Authors:  Hon Shing Ong; Marcus Ang; Jodhbir Mehta
Journal:  Br J Ophthalmol       Date:  2020-07-24       Impact factor: 4.638

10.  Eye bank versus surgeon prepared DMEK tissues: influence on adhesion and re-bubbling rate.

Authors:  Vito Romano; Ahmed Kazaili; Luca Pagano; Kunal Ajit Gadhvi; Mitchell Titley; Bernhard Steger; Luis Fernández-Vega-Cueto; Alvaro Meana; Jesus Merayo-Lloves; Ponzin Diego; Riaz Akhtar; Hannah J Levis; Stefano Ferrari; Stephen B Kaye; Mohit Parekh
Journal:  Br J Ophthalmol       Date:  2020-10-30       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.